Search for drugs:

TENAPANOR HYDROCHLORIDE


DIR Classification


Classification:Ambiguous
Severity Score:1.0

Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF

  • CLINICAL PHARMACOLOGY
  • Pharmacodynamics
  • Cardiac Electrophysiology
  • At 3 times the mean maximum exposure of M1 at the recommended dosage, there were no clinically relevant effects on the QTc interval.

Postmarketing Surveillance

Contingency Table:

Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
7
38381580

Odds Ratio = 0.0

Drug Property Information



ATC Code(s):
  • A06AX08 - tenapanor hydrochloride
    • A06AX0 -
    • A06AX - Other laxatives
    • A06A - LAXATIVES
    • A06 - LAXATIVES
    • A - ALIMENTARY TRACT AND METABOLISM
Active Ingredient:TENAPANOR HYDROCHLORIDE
Active Ingredient UNII:50605O2ZNS
Drugbank ID:DB11761
PubChem Compound:71587953
CTD ID:C000599417
PharmGKB:
CAS Number:1234423-95-0
Dosage Form(s):tablet
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure:
SMILE Code:
CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2

Reference

N/A

Disclaimer:

The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.

Any mention of commercial products is for clarification and not intended as endorsement.